As China’s one-child policy comes to an end, the proportion of an aging population will continue to rise for a long time to come. Those who have just entered the elderly demographic are more concerned about their health issues than their predecessors and are actively taking steps to improve it. In an era when maintaining good health was considered a luxury, especially given the primary focus on stomach-related matters, today the situation has vastly improved. Compared to their elders, the new generation of middle-aged and older adults not only pay greater attention to their physical well-being but also enjoy stronger financial resources. The resulting increase in productive capacity—and the accompanying robust growth of the healthcare industry—are clearly evident.

　　Another embarrassing fact is that the physical condition of Chinese people is cause for concern. As we can see from the state of children’s education, promoting robust health seems to be at odds with the demands of an exam-oriented educational system. Teenagers of school age are subjected to exams and homework at all levels. After spending most of my time on these activities, my sleep has been severely reduced, leaving me with little time for anything else—except playing golf and occasionally swimming. A wealth of data indicates that the physical condition of young Chinese people is indeed worrisome.

　　Some young people with weak physical health have developed many unhealthy habits. According to a survey, taking smoking as an example, the number of smokers in China is aging and becoming increasingly female. China has now become the world’s largest producer of tobacco—and also its largest consumer. Moreover, an increasing number of teenagers are turning away from video games, especially those left-behind children whose parents work at home.

　　The situation in the workplace is also far from optimistic. Compared with that in developed countries in Europe and the U.S., Chinese workplaces—due to their industrial structure and low productivity—see employees facing much longer overtime hours, not only in factories and construction sites but even in office settings. Most restaurants and entertainment venues are bustling with business activities. Even those attending banquets feel overwhelmed; under pressure to perform, many salespeople are forced to work until dawn—and some have already fallen ill. Rising housing prices are placing ever-greater survival pressures on young people who come from rural or less-developed regions. To afford hefty down payments—often exceeding 50 percent of their salaries—and monthly mortgage payments, those who have never enjoyed robust physical or mental health from childhood are bound to experience more serious psychological and physical problems, especially if they are only children. The most telling statistic is the declining success rate of conception among people of the right reproductive age.

　　China, which has just stepped onto the threshold of modernization, is now facing the overuse and depletion of its healthcare resources. As professionals working in the pharmaceutical and healthcare equipment sectors, they are currently enjoying favorable conditions brought about by the rapid growth of the broader healthcare industry—a situation that is both encouraging and heartbreaking. As the massive investments spurred by GMP policies in pharmaceutical equipment come to an end, the issues discussed in this article are increasingly becoming pressing demands for the development of the larger healthcare sector. The growth in market demand has sharply contrasted with the current supply levels within the industry, and this gap is now aligning with the country’s overarching strategic objectives. The situation is strikingly similar across the board: whether it’s pharmaceuticals and healthcare products or upstream equipment manufacturers, there’s an overabundance of low-end products alongside a scarcity of high-quality ones. Promoting supply-side structural reform and steadfastly adjusting production capacity have thus become urgent challenges confronting the entire healthcare industry.

　　The vast majority of Western medicines available in China are generic drugs. Many generic drugs on the market are wasting resources, suffering from overcapacity, low profitability, and poor efficacy. Since 2016, the National Medical Products Administration has been conducting consistency evaluations in the pharmaceutical industry. Industry leaders with high-quality resources have consistently passed these evaluations and continue to do so. While these companies gain a first-mover advantage, they have also embarked on another round of large-scale mergers and acquisitions. For those drug varieties that have successfully passed the consistency evaluation, production capacity is being expanded, and major orders are being secured. In terms of product strategy, companies are continuing to increase R&D investment on the one hand, while on the other hand, they are starting to acquire more advanced and smarter production lines to further enhance manufacturing efficiency and reduce production costs. The domestic pharmaceutical machinery market closely resembles the downstream pharmaceutical market. Foreign imported products command extremely high prices, and there is a shortage of high-end domestically produced products. However, the market is flooded with crude, low-end products.